Determination of meprobamate in pharmaceutical dosage forms also containing carbromal by liquid chromatography and indirect photometric detection.
In a pharmaceutical form also containing carbromal, meprobamate could not be quantified selectively by classical methods described in pharmacopoeias due to a significant interference from carbromal. Consequently, reversed-phase HPLC methods have been developed to separate the two active ingredients using indirect photometric detection to visualize and determine meprobamate which has very poor chromophoric properties. Different parameters influencing the sensitivity of the indirect response, such as the nature of the highly absorbing compound added to the mobile phase (the marker) as well as the methanol content and the pH of this phase, have been studied. Two chromatographic systems containing benzoic acid or cinnamic acid as the marker, have been optimized and validated. Good linearity and reproducibility have been obtained with both systems but the cinnamic acid method has the advantage that meprobamate and carbromal can be determined simultaneously at 273 nm.
Laboratory of Drug Analysis, University of Liège, Belgium.
I
I
Bechet
A
A
Ceccato
P
P
Hubert
P
P
Herné
J
J
Crommen
D001565:Benzoates / Q000737:chemistry; D019817:Benzoic Acid; D002851:Chromatography, High Pressure Liquid; D002934:Cinnamates / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D008620:Meprobamate / Q000032:analysis* / Q000302:isolation & purification; D012015:Reference Standards; D013056:Spectrophotometry, Ultraviolet; D013607:Tablets / Q000737:chemistry; D014508:Urea / Q000032:analysis* / Q000302:isolation & purification
D001565:Benzoates; D002934:Cinnamates; D013607:Tablets; C029010:cinnamic acid; D019817:Benzoic Acid; D014508:Urea; D008620:Meprobamate